Povej prijatelju o tem izdelku:
Target Validation in Drug Discovery Dillon
Do you have a profile? Prijava
Prejemajte obvestila o novih izdajah izvajalca Dillon
Kaj pravijo naše stranke:
Dodaj na svoj seznam želja iMusic
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
| Medij | Knjige Hardcover Book (Knjiga s trdim hrbtom in platnicami) |
| Izdano | 1. septembra 2006 |
| ISBN13 | 9780123693938 |
| Založniki | Elsevier Science Publishing Co Inc |
| Strani | 296 |
| Dimenzije | 184 × 260 × 24 mm · 820 g |
| Urednik | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
| Urednik | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
